James M. Reuben

Research interests

Publications

• Inflammatory breast cancer biology: the tumour microenvironment is key

  Nature reviews. Cancer · 2018 · https://doi.org/10.1038/s41568-018-0010-y

• The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper

  Critical Reviews in Oncology/Hematology · 2018 · https://doi.org/10.1016/j.critrevonc.2018.12.004

• Phase Ib Pilot Study to Evaluate Reparixin in Combination with Weekly Paclitaxel in Patients with HER-2–Negative Metastatic Breast Cancer

  Clinical Cancer Research · 2017 · https://doi.org/10.1158/1078-0432.ccr-16-2748

• Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia

  Blood · 2013 · https://doi.org/10.1182/blood-2013-01-478222

• Uncovering the Molecular Secrets of Inflammatory Breast Cancer Biology: An Integrated Analysis of Three Distinct Affymetrix Gene Expression Datasets

  Clinical Cancer Research · 2013 · https://doi.org/10.1158/1078-0432.ccr-12-2549

• Inflammatory response, immunosuppression, and cancer recurrence after perioperative blood transfusions

  British Journal of Anaesthesia · 2013 · https://doi.org/10.1093/bja/aet068

• Epithelial–Mesenchymal Transition and Stem Cell Markers in Patients with HER2-Positive Metastatic Breast Cancer

  Molecular Cancer Therapeutics · 2012 · https://doi.org/10.1158/1535-7163.mct-12-0460

• Comparison of assay methods for detection of circulating tumor cells in metastatic breast cancer: AdnaGen AdnaTest BreastCancer Select/Detect™ versus Veridex CellSearch™ system

  International Journal of Cancer · 2011 · https://doi.org/10.1002/ijc.26111

• Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment

  Breast Cancer Research · 2011 · https://doi.org/10.1186/bcr2907

• Mesenchymal Stem Cells Promote Mammosphere Formation and Decrease E-Cadherin in Normal and Malignant Breast Cells

  PLoS ONE · 2010 · https://doi.org/10.1371/journal.pone.0012180

• Breast Cancer Metastasis: Challenges and Opportunities

  Cancer Research · 2009 · https://doi.org/10.1158/0008-5472.can-09-0099

• Lenalidomide induces complete and partial remissions in patients with relapsed and refractory chronic lymphocytic leukemia

  Blood · 2008 · https://doi.org/10.1182/blood-2007-12-130120

• Circulating Tumor Cells: A Novel Prognostic Factor for Newly Diagnosed Metastatic Breast Cancer

  Journal of Clinical Oncology · 2005 · https://doi.org/10.1200/jco.2005.08.140

• Antitumor Activity in Melanoma and Anti-Self Responses in a Phase I Trial With the Anti-Cytotoxic T Lymphocyte–Associated Antigen 4 Monoclonal Antibody CP-675,206

  Journal of Clinical Oncology · 2005 · https://doi.org/10.1200/jco.2005.01.109

• A Cytokine-Based Neuroimmunologic Mechanism of Cancer-Related Symptoms

  NeuroImmunoModulation · 2004 · https://doi.org/10.1159/000079408

• Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer

  New England Journal of Medicine · 2004 · https://doi.org/10.1056/nejmoa040766

• Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy

  Cytokine · 2003 · https://doi.org/10.1016/j.cyto.2003.10.004

• Nuclear factor–κB and STAT3 are constitutively active in CD138+ cells derived from multiple myeloma patients, and suppression of these transcription factors leads to apoptosis

  Blood · 2003 · https://doi.org/10.1182/blood-2003-06-2151

• Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcome

  Blood · 2001 · https://doi.org/10.1182/blood.v97.1.256

• Pivotal Phase III Trial of Two Dose Levels of Denileukin Diftitox for the Treatment of Cutaneous T-Cell Lymphoma

  Journal of Clinical Oncology · 2001 · https://doi.org/10.1200/jco.2001.19.2.376

• Soluble TNF-α receptor 1 and IL-6 plasma levels in humans subjected to the sleep deprivation model of spaceflight

  Journal of Allergy and Clinical Immunology · 2001 · https://doi.org/10.1067/mai.2001.112270

• Phase I trial of a ligand fusion-protein (DAB389IL-2) in lymphomas expressing the receptor for interleukin-2.

  PubMed · 1998 · https://doi.org/10.1182/blood.v91.2.399

• Treatment of hairy cell leukemia with recombinant alpha-interferon

  Blood · 1986 · https://doi.org/10.1182/blood.v68.2.493.493

• Liposomal Amphotericin B for the Treatment of Systemic Fungal Infections in Patients with Cancer: A Preliminary Study

  The Journal of Infectious Diseases · 1985 · https://doi.org/10.1093/infdis/151.4.704

• Alpha Interferon for Induction of Remission in Hairy-Cell Leukemia

  New England Journal of Medicine · 1984 · https://doi.org/10.1056/nejm198401053100104

Current projects

No projects listed.